Statement of Changes in Beneficial Ownership (4)
May 10 2021 - 4:26PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Cambre Jerome |
2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC.
[
VMD
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Vice President of Sales |
(Last)
(First)
(Middle)
625 E. KALISTE SALOOM RD. |
3. Date of Earliest Transaction
(MM/DD/YYYY)
5/9/2021 |
(Street)
LAFAYETTE, LA 70508
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Shares | 5/9/2021 | | M | | 14621 | A | (1) | 77409 | D | |
Common Shares | 5/9/2021 | | D | | 14621 | D | $9.57 | 62788 | D | |
Common Shares | 5/9/2021 | | M | | 1137 | A | (1) | 63925 | D | |
Common Shares | 5/9/2021 | | D | | 1137 | D | $9.57 | 62788 | D | |
Common Shares | 5/9/2021 | | M | | 924 | A | (1) | 63712 | D | |
Common Shares | 5/9/2021 | | D | | 924 | D | $9.57 | 62788 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Phantom Share Units | (2) | 5/9/2021 | | A | | 3086 | | (3) | 5/9/2024 | Common Shares | 3086.0 | $0 | 3086 | D | |
Phantom Share Units | (2) | 5/9/2021 | | M | | | 14621 | (4) | 5/9/2021 | Common Shares | 14621.0 | $0 | 0 | D | |
Phantom Share Units | (2) | 5/9/2021 | | M | | | 1137 | (5) | 5/9/2022 | Common Shares | 1137.0 | $0 | 1137 | D | |
Phantom Share Units | (2) | 5/9/2021 | | M | | | 924 | (6) | 5/9/2023 | Common Shares | 924.0 | $0 | 1848 | D | |
Explanation of Responses: |
(1) | Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. |
(2) | Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. |
(3) | Represents an award granted in 2021 under the Issuer's Phantom Share Unit Plan which vests in equal installments on May 9, 2022, May 9, 2023, and May 9, 2024, subject to the Reporting Person's continued employment with the Issuer on such vesting date. |
(4) | Represents an award granted in 2018 under the Issuer's Phantom Share Unit Plan which vests on May 9, 2021, subject to the Reporting Person's continued employment with the Issuer on such vesting date. |
(5) | Represents an award granted in 2019 under the Issuer's Phantom Share Unit Plan which vests in equal installments on May 9, 2021 and May 9, 2022, subject to the Reporting Person's continued employment with the Issuer on such vesting date. |
(6) | Represents an award granted in 2020 under the Issuer's Phantom Share Unit Plan which vests in equal installments on May 9, 2021, May 9, 2022, and May 9, 2023, subject to the Reporting Person's continued employment with the Issuer on such vesting date. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Cambre Jerome 625 E. KALISTE SALOOM RD. LAFAYETTE, LA 70508 |
|
| Vice President of Sales |
|
Signatures
|
/s/ Jerome Cambre | | 5/10/2021 |
**Signature of Reporting Person | Date |
VieMed Healthcare (NASDAQ:VMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
VieMed Healthcare (NASDAQ:VMD)
Historical Stock Chart
From Sep 2023 to Sep 2024